FinishedObservation Study

Noncurative Endoscopic Resection of Colorectal Adenocarcinoma

For Condition: Noncurative Resection

ID: NCT03987828

Horizon Patient Guidance Summary

Our intelligence engine has synthesized this trial record to answer your most important questions in clear, simple terms:

How it’s taken

Diet & Lifestyle / Therapy Care

Expected Availability Horizon

General pipeline timeline

StageGeneral evaluation study exploring treatment methods.

EligibleThis study is looking exclusively for patients diagnosed with the condition.

About This Clinical Trial

Patients with noncurative resection after ESD for CRC were considered for additional surgical treatment. Then, they either underwent surgery with curative intent or did not, according to patients choice and surgeons indication / contraindication. We performed a retrospective revision of outcome data by clinical report review or phone calls.

Read Full Scientific Objectives & Methods

Study Timeline & Quick Facts

Trial Status

Study Finished

Total Target Enrollment

500 patients (Actual)

Study Start Date

2019-09-01

Est. Primary Completion

2020-12-31

Can I Join This Study?

Suitable For

Everyone welcome

Ages Welcome

18 Years and older

Full Criteria Checklist

Who Can Join

\- undergoing non-curative colorectal endoscopic submucosal dissection (ESD).

Who Cannot Join

Histology other than cancer (adenocarcinoma).
History of inflammatory bowel disease (IBD).
Genetic conditions predisposing to CR.
Lost to follow up or less than 6 months of follow up.

What is this Study Measuring?

Primary Outcome Measures

Survival — Time Frame: 6 Months
Overall survival cancer-specific survival and disease-free survival rate after noncurative ESD.

Where to Participate

This trial is recruiting at 1 study facilities worldwide. Click below to see if there is a clinic or hospital in your area:

Show All 1 Facilities & Contact Sites

Endoscopy Unit, Humanitas Research Hospital

Rozzano, Milano, Italy

Sponsoring Teams & Contacts

Lead Sponsoring Institution

Istituto Clinico Humanitas

Clinical Trial Application Copilot

Want to apply or inquire about joining this study? Fill out this simple questionnaire, and our assistant will instantly generate a professional email draft you can copy and send to the central contact coordinator listed above!

Your Full Name

Your Age

Diagnosed Condition

Generated Professional Email Draft:

Draft ready to copy & send

Subject: Inquiry about clinical trial enrollment: NCT03987828 - Noncurative Endoscopic Resection of Colorectal Adenocarcinoma

Dear Study Coordinator / Research Team, I hope this message finds you well. My name is [Your Name], and I am writing to express my strong interest in participating in the clinical trial titled "Noncurative Endoscopic Resection of Colorectal Adenocarcinoma" (NCT ID: NCT03987828). I am [Age] years old and have been diagnosed with Noncurative Resection. I have reviewed the eligibility criteria for this study on Med Code Info and believe I may be a suitable candidate. Could you please let me know if this study is actively enrolling patients at any site near my location, and what the next steps are to undergo screening? Thank you for your time and research efforts. Warm regards, [Your Name]

Scientific Literature & Publications

Spadaccini M, Bourke MJ, Maselli R, Pioche M, Bhandari P, Jacques J, Haji A, Yang D, Albeniz E, Kaminski MF, Messmann H, Herreros de Tejada A, Sferrazza S, Pekarek B, Rivory J, Geyl S, Gulati S, Draganov P, Shahidi N, Hossain E, Fleischmann C, Vespa E, Iannone A, Alkandari A, Hassan C, Repici A; ESD Western Alliance (EWA). Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer. Gut. 2022 Sep 7;71(10):1998-2004. doi: 10.1136/gutjnl-2020-323897.PubMed ↗

View Official Medical/Scientific Title

Long-term Outcomes After Noncurative Endoscopic Resection of Colorectal Adenocarcinoma